Dermata Therapeutics, Inc. Warrant (DRMAW)
Dermata Therapeutics, Inc. Warrant (DRMAW) has a 15-report earnings history dating back to Aug 15, 2022. Its average absolute post-earnings move is ±0.02%, and 100.0% of those reactions were positive. Its largest post-earnings gain was +0.35% (Aug 10, 2023) and its largest decline was +0% (Mar 26, 2026). The next earnings report is predicted for 2026-08-10 (estimated).
Earnings Price Reaction
Scroll to zoom, drag to pan — click earnings dots for details
Earnings Impact
Total Earnings
15
Avg Abs. Movement
±0.02%
Positive %
100.0%
Negative %
0.0%
Historical Earnings Statistics
| Date | Timing | Open | High | Close | Volume | Movement % | SEC Filing |
|---|---|---|---|---|---|---|---|
| Mar 26, 2026 | ☽ POST | $0.02 | $0.02 | $0.02 | 0 | +0% | open_in_new |
| Nov 14, 2025 | ☽ POST | $0.02 | $0.02 | $0.02 | 0 | +0% | open_in_new |
| Aug 13, 2025 | ☽ POST | $0.02 | $0.02 | $0.02 | 0 | +0% | open_in_new |
| May 14, 2025 | ☀ PRE | $0.02 | $0.02 | $0.02 | 0 | +0% | open_in_new |
| Mar 17, 2025 | ☽ POST | $0.02 | $0.02 | $0.02 | 0 | +0% | open_in_new |
| Nov 14, 2024 | ☽ POST | $0.02 | $0.02 | $0.02 | 0 | +0% | open_in_new |
| Aug 07, 2024 | ☽ POST | $0.02 | $0.02 | $0.02 | 0 | +0% | open_in_new |
| May 15, 2024 | ☽ POST | $0.02 | $0.02 | $0.02 | 0 | +0% | open_in_new |
| Mar 21, 2024 | ☽ POST | $0.02 | $0.02 | $0.02 | 0 | +0% | open_in_new |
| Nov 09, 2023 | ☽ POST | $0.03 | $0.03 | $0.03 | 0 | +0% | open_in_new |
| Aug 10, 2023 | ☽ POST | $0.03 | $0.03 | $0.03 | 0 | +0.35% | open_in_new |
| May 11, 2023 | ☽ POST | $0.02 | $0.02 | $0.02 | 0 | +0% | open_in_new |
| Feb 21, 2023 | ☽ POST | $0.02 | $0.02 | $0.02 | 0 | +0% | open_in_new |
| Nov 10, 2022 | ☽ POST | $0.07 | $0.07 | $0.07 | 0 | +0% | open_in_new |
| Aug 15, 2022 | ☽ POST | $0.07 | $0.07 | $0.07 | 0 | +0% | open_in_new |
Earnings Count
15
Total earnings in dataset
Avg Abs. Movement
±0.02%
Avg % price change on earnings
SEC Filing Types
Recent SEC Filings
9 most recent| Form | Date Filed | View on EDGAR |
|---|---|---|
| S-8 | 20260604 | open_in_new SEC.gov |
| SCHEDULE 13D | 20260601 | open_in_new SEC.gov |
| EFFECT | 20260529 | open_in_new SEC.gov |
| 424B3 | 20260529 | open_in_new SEC.gov |
| 8-K | 20260527 | open_in_new SEC.gov |
| S-3/A | 20260522 | open_in_new SEC.gov |
| 10-Q | 20260513 | open_in_new SEC.gov |
| 8-K | 20260513 | open_in_new SEC.gov |
| SCHEDULE 13G/A | 20260513 | open_in_new SEC.gov |
Frequently asked about DRMAW earnings
When does Dermata Therapeutics, Inc. Warrant report earnings next? expand_more
Dermata Therapeutics, Inc. Warrant (DRMAW)'s next earnings date is estimated for 2026-08-10. This is a prediction based on its historical quarterly reporting pattern, not a company-confirmed date.
How much does DRMAW stock move after earnings? expand_more
Over 15 reports, DRMAW has moved an average of ±0.02% the session after earnings, closing higher 100.0% of the time.
What was DRMAW's biggest post-earnings move? expand_more
DRMAW's largest post-earnings gain on record was +0.35% on Aug 10, 2023, and its largest decline was +0% on Mar 26, 2026.
Where can I find Dermata Therapeutics, Inc. Warrant's SEC filings? expand_more
All of Dermata Therapeutics, Inc. Warrant's SEC filings — 10-K, 10-Q, 8-K and more — are listed in the SEC filings section on this page, each linking to the original document on SEC.gov.
Sector peers
- Aardvark Therapeutics, Inc. (AARD) earnings history chevron_right
- AbCellera Biologics Inc. Common Shares (ABCL) earnings history chevron_right
- ABEONA THERAPEUTICS INC. (ABEO) earnings history chevron_right
- Acumen Pharmaceuticals, Inc. Common Stock (ABOS) earnings history chevron_right
- Arbutus Biopharma Corp (ABUS) earnings history chevron_right
- ABVC BioPharma, Inc. Common Stock (ABVC) earnings history chevron_right
- ACADIA PHARMACEUTICALS INC (ACAD) earnings history chevron_right
- Adicet Bio, Inc. Common Stock (ACET) earnings history chevron_right
- Acadia Healthcare Company, Inc. Common Stock (ACHC) earnings history chevron_right
- Achieve Life Sciences, Inc. Common Shares (ACHV) earnings history chevron_right